BioVie Inc. Finite-Lived Intangible Assets, Accumulated Amortization
BioVie Inc. (BIVI) had Finite-Lived Intangible Assets, Accumulated Amortization of $2.29 million as of 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization · last filed 2026-08-13
- 2026-06-30: Finite-Lived Intangible Assets, Accumulated Amortization $2.29M.
- 2026-03-31: Finite-Lived Intangible Assets, Accumulated Amortization $2.29M.
- 2025-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $2.23M.
- 2025-09-30: Finite-Lived Intangible Assets, Accumulated Amortization $2.17M.
| Period end | Finite-Lived Intangible Assets, Accumulated Amortization | Finite-Lived Intangible Assets, Accumulated Amortization as first filed |
|---|---|---|
| 2026-06-30 | $2.29M 10-K · filed 2026-08-13 | |
| 2026-03-31 | $2.29M S-1/A · filed 2026-08-06 | |
| 2025-12-31 | $2.23M 10-Q · filed 2026-02-06 | |
| 2025-09-30 | $2.17M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $2.12M 10-K · filed 2026-08-13 | |
| 2025-03-31 | $2.06M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $2.00M 10-Q · filed 2025-02-11 | |
| 2024-09-30 | $1.94M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $1.89M S-1/A · filed 2026-08-06 | |
| 2024-03-31 | $1.83M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $1.77M 10-Q · filed 2024-02-13 | |
| 2023-09-30 | $1.71M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $1.66M 10-K · filed 2024-09-30 | |
| 2023-03-31 | $1.60M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $1.54M 10-Q · filed 2023-02-10 | |
| 2022-09-30 | $1.48M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $1.43M 10-K · filed 2023-08-16 | |
| 2022-03-31 | $1.37M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $1.31M 10-Q · filed 2022-02-08 | |
| 2021-09-30 | $1.26M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $1.20M 10-K · filed 2022-09-27 | |
| 2021-03-31 | $1.14B 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $1.08M 10-Q · filed 2021-01-29 | |
| 2020-09-30 | $1.03M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $968.54K 10-K · filed 2021-08-30 | |
| 2020-03-31 | $911.20K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $853.86K 10-Q · filed 2020-02-13 | |
| 2019-09-30 | $796.51K 10-Q · filed 2019-11-19 | |
| 2019-06-30 | $739.17K 10-K/A · filed 2020-08-07 | |
| 2019-03-31 | $681.82K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $624.48K 10-Q · filed 2019-02-12 | |
| 2018-09-30 | $567.13K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $509.79K 10-K · filed 2019-09-27 | |
| 2018-03-31 | $1.84M 10-Q · filed 2018-05-14 | |
| 2017-06-30 | $280.41K 10-K · filed 2018-10-05 | $2.01M 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |